report published by Infinium Global Research on bleeding disorders treatment market
provides an in-depth analysis of segments and sub-segments in the global as well
as regional bleeding disorders treatment market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
bleeding disorders treatment market over the short term as well as long term.
The report is a comprehensive presentation of trends, forecast and dollar
values of global bleeding disorders treatment market. According to the report,
the global bleeding disorders treatment market is projected to grow at a CAGR
of 7.8% over the forecast period of 2019-2025.
disorder is a medical situation in which normal clotting function of blood is
adversely affected. The clotting function is also known as coagulation in which
blood changes from liquid to a solid state. The bleeding disorder can cause
anomalous bleeding outside and inside the body. The most common type of
bleeding disorder is von Willebrand disease (VWD) in women. There are different
bleeding disorders treatment are available which includes iron supplementation,
fresh frozen plasma, platelet transfusion, and antifibrinolytic drugs.
the most well-known inherited bleeding disorder in which the blood does not
clot properly. The growing incidences of hemophilia across the world escalate
the demand for bleeding disorders treatment market. As per Hemophilia
Federation of America, four hundred thousand people worldwide were living with
hemophilia, and about 20,000 are living with it in the United States. Moreover,
growing R&D investment for the development of hemophilia products, rising
awareness about bleeding disorders and favorable compensation policies is
another factor responsible for the growth of the same. Furthermore, according
to the Centers for Disease Control and Prevention, near about 400 babies were
born with hemophilia Each year. However, the high cost of hemophilia drugs may
hamper the growth of bleeding disorders treatment market. Availability of cheap
generic drugs is expected to provide growth opportunities in the countries of
Latin America, the Middle East, and Africa.
On the basis
regions, North America is accounted to hold the largest share in the bleeding
disorder treatment market due to highly developed infrastructures. As per National
Hemophilia Foundation, VWD is believed to be the most common bleeding disorder.
It is estimated to affect up to 1% of the US population. The Asia Pacific
region is anticipated to be the highest growth rate during the forecast period.
The growth of this region is attributed due to growing awareness of bleeding
disorders in emerging countries such as China and India and development in
The report on
global bleeding disorders treatment market covers segments such as disease
type, drug class, and distribution channel. On the basis of
disease type, the sub-markets include hemophilia a, hemophilia b, von
willebrand disease, and other disease types. On the basis of drug
class, the sub-markets include plasma derived coagulation factor concentrates,
recombinant coagulation factor concentrates, antibrinolytics, desmopressin,
fibrin sealant, and other drug classes. On the basis of distribution channel,
the sub-markets include hospital pharmacies, retail pharmacies, and compounding
provides profiles of the companies in the market such as Compounding Pharmacies
Bioverativ Inc., Janssen Global Services, LLC, Amgen Inc., Sanofi S.A.,
Bristol-Myers Squibb Company, Xenetic Biosciences, Inc., Pfizer Inc., Alnylam
Pharmaceuticals Inc., Baxter International Inc., and Bayer AG.
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of bleeding disorders treatment market.
Moreover, the study highlights current market trends and provides forecast from
2019-2025. We also have highlighted future trends in the market that will
affect the demand during the forecast period. Moreover, the competitive
analysis given in each regional market brings an insight into the market share
of the leading players.